COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY
1. A pharmaceutical composition deliverable from a metered dose inhaler, the pharmaceutical composition comprising: a propellant of pharmaceutical grade 1,1-Difluoroethane (HFC-152a); a plurality of active agent particles; and a plurality of phospholipid particles comprising perforated microstructur...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | RIEBE, Michael LACHACZ, Kellisa Beth LECHUGA-BALLESTEROS, David ARCHBELL, James JOSHI, Vidya B |
| description | 1. A pharmaceutical composition deliverable from a metered dose inhaler, the pharmaceutical composition comprising: a propellant of pharmaceutical grade 1,1-Difluoroethane (HFC-152a); a plurality of active agent particles; and a plurality of phospholipid particles comprising perforated microstructures; wherein the active agent particles comprise an active agent selected from a long-acting muscarinic antagonist (LAMA), a long-acting P2-agonist (LABA), a short-acting beta-agonist (SABA), an inhaled corticosteroid (ICS), and a non-corticosteroid anti-inflammatory agent. A metered dose inhaler comprising a canister with an outlet valve including an actuator for dispensing a metered amount of said pharmaceutical composition, wherein the canister contains the pharmaceutical composition. Said composition for use in the treatment of a pulmonary disease or disorder. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4452230A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4452230A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4452230A13</originalsourceid><addsrcrecordid>eNrjZLB29vcN8A_2DPH09wvWUfB1DfHwdwlWcPRzUQiODA5x9Q1WcPMPUnB0DfIP9vdRcAkKdVdwcfXxDHMNiuRhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuASYmpkZGxgaOhsZEKAEAqxMpFg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY</title><source>esp@cenet</source><creator>RIEBE, Michael ; LACHACZ, Kellisa Beth ; LECHUGA-BALLESTEROS, David ; ARCHBELL, James ; JOSHI, Vidya B</creator><creatorcontrib>RIEBE, Michael ; LACHACZ, Kellisa Beth ; LECHUGA-BALLESTEROS, David ; ARCHBELL, James ; JOSHI, Vidya B</creatorcontrib><description>1. A pharmaceutical composition deliverable from a metered dose inhaler, the pharmaceutical composition comprising: a propellant of pharmaceutical grade 1,1-Difluoroethane (HFC-152a); a plurality of active agent particles; and a plurality of phospholipid particles comprising perforated microstructures; wherein the active agent particles comprise an active agent selected from a long-acting muscarinic antagonist (LAMA), a long-acting P2-agonist (LABA), a short-acting beta-agonist (SABA), an inhaled corticosteroid (ICS), and a non-corticosteroid anti-inflammatory agent. A metered dose inhaler comprising a canister with an outlet valve including an actuator for dispensing a metered amount of said pharmaceutical composition, wherein the canister contains the pharmaceutical composition. Said composition for use in the treatment of a pulmonary disease or disorder.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241030&DB=EPODOC&CC=EP&NR=4452230A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241030&DB=EPODOC&CC=EP&NR=4452230A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RIEBE, Michael</creatorcontrib><creatorcontrib>LACHACZ, Kellisa Beth</creatorcontrib><creatorcontrib>LECHUGA-BALLESTEROS, David</creatorcontrib><creatorcontrib>ARCHBELL, James</creatorcontrib><creatorcontrib>JOSHI, Vidya B</creatorcontrib><title>COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY</title><description>1. A pharmaceutical composition deliverable from a metered dose inhaler, the pharmaceutical composition comprising: a propellant of pharmaceutical grade 1,1-Difluoroethane (HFC-152a); a plurality of active agent particles; and a plurality of phospholipid particles comprising perforated microstructures; wherein the active agent particles comprise an active agent selected from a long-acting muscarinic antagonist (LAMA), a long-acting P2-agonist (LABA), a short-acting beta-agonist (SABA), an inhaled corticosteroid (ICS), and a non-corticosteroid anti-inflammatory agent. A metered dose inhaler comprising a canister with an outlet valve including an actuator for dispensing a metered amount of said pharmaceutical composition, wherein the canister contains the pharmaceutical composition. Said composition for use in the treatment of a pulmonary disease or disorder.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB29vcN8A_2DPH09wvWUfB1DfHwdwlWcPRzUQiODA5x9Q1WcPMPUnB0DfIP9vdRcAkKdVdwcfXxDHMNiuRhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuASYmpkZGxgaOhsZEKAEAqxMpFg</recordid><startdate>20241030</startdate><enddate>20241030</enddate><creator>RIEBE, Michael</creator><creator>LACHACZ, Kellisa Beth</creator><creator>LECHUGA-BALLESTEROS, David</creator><creator>ARCHBELL, James</creator><creator>JOSHI, Vidya B</creator><scope>EVB</scope></search><sort><creationdate>20241030</creationdate><title>COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY</title><author>RIEBE, Michael ; LACHACZ, Kellisa Beth ; LECHUGA-BALLESTEROS, David ; ARCHBELL, James ; JOSHI, Vidya B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4452230A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RIEBE, Michael</creatorcontrib><creatorcontrib>LACHACZ, Kellisa Beth</creatorcontrib><creatorcontrib>LECHUGA-BALLESTEROS, David</creatorcontrib><creatorcontrib>ARCHBELL, James</creatorcontrib><creatorcontrib>JOSHI, Vidya B</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RIEBE, Michael</au><au>LACHACZ, Kellisa Beth</au><au>LECHUGA-BALLESTEROS, David</au><au>ARCHBELL, James</au><au>JOSHI, Vidya B</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY</title><date>2024-10-30</date><risdate>2024</risdate><abstract>1. A pharmaceutical composition deliverable from a metered dose inhaler, the pharmaceutical composition comprising: a propellant of pharmaceutical grade 1,1-Difluoroethane (HFC-152a); a plurality of active agent particles; and a plurality of phospholipid particles comprising perforated microstructures; wherein the active agent particles comprise an active agent selected from a long-acting muscarinic antagonist (LAMA), a long-acting P2-agonist (LABA), a short-acting beta-agonist (SABA), an inhaled corticosteroid (ICS), and a non-corticosteroid anti-inflammatory agent. A metered dose inhaler comprising a canister with an outlet valve including an actuator for dispensing a metered amount of said pharmaceutical composition, wherein the canister contains the pharmaceutical composition. Said composition for use in the treatment of a pulmonary disease or disorder.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4452230A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T03%3A22%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RIEBE,%20Michael&rft.date=2024-10-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4452230A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |